Mogrify and Sangamo in license agreement for ‘off-the-shelf’ CAR-Treg
Sangamo plans to utilize Mogrify’s cell conversion technology to develop CAR-Treg cell therapies.
Archives for April 23, 2020
MilliporeSigma set to build $100m facility for viral and gene therapies
The facility will be the company’s second facility in Carlsbad specifically for its BioReliance viral and gene therapy service.